Close Menu

NEW YORK – Fulgent Genetics is looking to build on a successful third quarter by expanding its international sales and offering more consumer-initiated genetic tests.

On Monday, the Temple City, California-based testing firm reported 84 percent growth year over year in total revenue, a 272 percent increase in billable tests year over year, and a net profit of $1.5 million.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.